Tigermed EMEA
Tigermed, a leading Chinese CRO, has expanded into the EMEA region to support diverse markets with efficient clinical trials, leveraging its expertise and partnerships to enhance drug development and deliver new therapies.
CROwding out the competition with an unmatched expertise
Who is Tigermed EMEA?
Local Team and Expertise
- 15 key offices/subsidiary companies across Western to Eastern Europe and 1 office in South Africa
- 160+ local employees in >25 European countries
From Trials To Treatment
- Complete go-to-market support for Pharmaceuticals, Medical Devices, Cosmetics and Food Supplements.
- Integrated Research, Safety, Medical and Regulatory Compliance.
- Tailored or full-service solutions for Clinical Research, Medical and Regulatory Affairs, including Registration, Post-Market support and GxP.
Proven Track Record
- 200+ phase I-IV trials from Tigermed EMEA team
- Supported our partners with their global clinical studies in >20 European countries
- Expertise in operation of large-scale vaccine clinical trials
0
+
Offices
0
+
European Countries Presence
0
+
Local European Employees
0
+
Phase I-IV Trials
Our Worldwide offices
Mission
Advance human heath through delivery excelence.
Vision
To be recognized as the leading global CRO.
Values
Integrity and Honesty.
Open and Inclusive
Collaborative and Accountable.
Professional and Innovative.
Brand Identity
Tigermed - Passion for Innovation
Global Excellence, China Expertise.
Leadership
Key Personnel